Principal Securities’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $559K | Buy |
1,714
+527
| +44% | +$172K | 0.01% | 814 |
|
|
2025
Q1 | $279K | Hold |
1,187
| – | – | 0.01% | 1008 |
|
|
2024
Q4 | $279K | Buy |
1,187
+1,066
| +881% | +$251K | 0.01% | 1004 |
|
|
2024
Q3 | $33.3K | Buy |
121
+6
| +5% | +$1.65K | ﹤0.01% | 1872 |
|
|
2024
Q2 | $27.9K | Buy |
115
+25
| +28% | +$6.08K | ﹤0.01% | 1891 |
|
|
2024
Q1 | $13.5K | Sell |
90
-12
| -12% | -$1.79K | ﹤0.01% | 2198 |
|
|
2023
Q4 | $19.5K | Buy |
+102
| New | +$19.5K | ﹤0.01% | 1929 |
|